FINLAND - Health Cap and LSP back EUR 5.7m Nexstim investment
Existing investors Health Cap and Life Sciences Partner (LSP) have, together The Finnish Funding Agency for Technology and Innovation (TEKES), invested close to EUR 6m into medical device company Nexstim Oy.
More on Early-stage
Forbion et al. in $196m round for NewAmsterdam Pharma
Company intends to use the fresh capital to finance the full phase-III development of its obicetrapib drug
Element Ventures leads €15.5m funding for fintech Minna
New funding takes the total the company has raised so far to €23m
EQT Ventures leads $18m round for Sana Labs
Latest round brings its total funding so far to $23m, having previously raised $4m in 2018 and $1m in 2017
HBM Healthcare leads €127m series-B for IO Biotech
Funding follows the US Food and Drug Administration granting the company breakthrough therapy designation for its lead programmes
Latest News
Polaris to launch sale of ProData Consult in 2021 – Mergermarket
Asset is reportedly due to come to market in 2021, with the sale process most likely starting in H1
Redalpine leads series-A for Felmo
Redalpine has led a series-A funding round for Germany-headquartered pet healthcare startup Felmo.
Holland Capital backs Dimensys
GP intends to boost the company's growth and consolidate its market position in the Benelux and DACH regions
WMS backs FruchtExpress MBI
GP is deploying equity via WMS III and is investing with future managing director Holger Schmitz